186 related articles for article (PubMed ID: 10478329)
21. Thyroid proliferative lesions induced by anti-thyroid drugs in rats are not always accompanied by sustained increases in serum TSH.
Onodera H; Mitsumori K; Takahashi M; Shimo T; Yasuhara K; Kitaura K; Takahashi M; Hayashi Y
J Toxicol Sci; 1994 Nov; 19(4):227-34. PubMed ID: 7533849
[TBL] [Abstract][Full Text] [Related]
22. The promoting effects of food dyes, erythrosine (Red 3) and rose bengal B (Red 105), on thyroid tumors in partially thyroidectomized N-bis(2-hydroxypropyl)-nitrosamine-treated rats.
Hiasa Y; Ohshima M; Kitahori Y; Konishi N; Shimoyama T; Sakaguchi Y; Hashimoto H; Minami S; Kato Y
Jpn J Cancer Res; 1988 Mar; 79(3):314-9. PubMed ID: 2836348
[TBL] [Abstract][Full Text] [Related]
23. Improvement of a two-stage carcinogenesis model to detect modifying effects of endocrine disrupting chemicals on thyroid carcinogenesis in rats.
Takagi H; Mitsumori K; Onodera H; Nasu M; Tamura T; Yasuhara K; Takegawa K; Hirose M
Cancer Lett; 2002 Apr; 178(1):1-9. PubMed ID: 11849735
[TBL] [Abstract][Full Text] [Related]
24. Lack of modifying effects of atrazine and/or tamoxifen on thyroid carcinogenesis in rats pretreated with N-bis(2-hydroxypropyl)nitrosamine (DHPN).
Son HY; Nishikawa A; Okazaki K; Lee K; Imazawa T; Hirose M
Food Chem Toxicol; 2003 Dec; 41(12):1811-6. PubMed ID: 14563406
[TBL] [Abstract][Full Text] [Related]
25. Effect of rat thyroid proliferative lesion development by intermittent treatment with sulfadimethoxine.
Shimo T; Mitsumori K; Onodera H; Takahashi M; Ueno Y; Katayama J; Saito A; Takahashi M
Cancer Lett; 1995 Sep; 96(2):209-18. PubMed ID: 7585459
[TBL] [Abstract][Full Text] [Related]
26. Regressive and non-regressive thyroid lesions of the rat induced by single injection of N-bis(2-hydroxypropyl)nitrosamine and iodine deficient diet.
Kanno J; Maronpot RR; Takahashi M; Kasuga T; Hayashi Y
Carcinogenesis; 1993 Nov; 14(11):2389-96. PubMed ID: 7902219
[TBL] [Abstract][Full Text] [Related]
27. Indomethacin induces small intestinal damage and inhibits amitrole-associated thyroid carcinogenesis in rats initiated with N-bis(2-hydroxypropyl)nitrosamine.
Imai T; Onose J; Hasumura M; Takizawa T; Hirose M
Toxicol Lett; 2006 Jun; 164(1):71-80. PubMed ID: 16384670
[TBL] [Abstract][Full Text] [Related]
28. Potassium perchlorate, potassium iodide, and propylthiouracil: promoting effect on the development of thyroid tumors in rats treated with N-bis(2-hydroxypropyl)-nitrosamine.
Hiasa Y; Kitahori Y; Kato Y; Ohshima M; Konishi N; Shimoyama T; Sakaguchi Y; Hashimoto H; Minami S; Murata Y
Jpn J Cancer Res; 1987 Dec; 78(12):1335-40. PubMed ID: 2828294
[TBL] [Abstract][Full Text] [Related]
29. Promotive effect of 4,4'-methylenebis(N,N-dimethyl)benzenamine on N-bis(2-hydroxypropyl)nitrosamine-induced thyroid tumors in Wistar rats.
Kitahori Y; Hiasa Y; Katoh Y; Konishi N; Ohshima M; Hashimoto H; Minami S; Sakaguchi Y
Cancer Lett; 1988 Jun; 40(3):275-81. PubMed ID: 3289735
[TBL] [Abstract][Full Text] [Related]
30. Relationships between serum thyroid stimulating hormone levels and development of thyroid tumors in rats treated with N-bis-(2-hydroxypropyl)nitrosamine.
Hiasa Y; Kitahori Y; Kitamura M; Nishioka H; Yane K; Fukumoto M; Ohshima M; Nakaoka S; Nishii S
Carcinogenesis; 1991 May; 12(5):873-7. PubMed ID: 2029752
[TBL] [Abstract][Full Text] [Related]
31. UDP-GT involvement in the enhancement of cell proliferation in thyroid follicular cell proliferative lesions in rats treated with thiourea and vitamin A.
Takegawa K; Mitsumori K; Onodera H; Mutai M; Kitaura K; Takahashi M; Uneyama C; Yasuhara K; Takahashi M; Yanai T; Masegi T; Hayashi Y
Arch Toxicol; 1997; 71(11):661-7. PubMed ID: 9363838
[TBL] [Abstract][Full Text] [Related]
32. Effect of propylthiouracil on the thyroid tumorigenesis induced by N-bis(2-hydroxypropyl)nitrosamine in rats.
Kitahori Y; Hiasa Y; Konishi N; Enoki N; Shimoyama T; Miyashiro A
Carcinogenesis; 1984 May; 5(5):657-60. PubMed ID: 6722982
[TBL] [Abstract][Full Text] [Related]
33. Detection of thyroid toxicants in a tier I screening battery and alterations in thyroid endpoints over 28 days of exposure.
O'Connor JC; Frame SR; Davis LG; Cook JC
Toxicol Sci; 1999 Sep; 51(1):54-70. PubMed ID: 10496677
[TBL] [Abstract][Full Text] [Related]
34. Mechanism of thiazopyr-induced effects on thyroid hormone homeostasis in male Sprague-Dawley rats.
Hotz KJ; Wilson AG; Thake DC; Roloff MV; Capen CC; Kronenberg JM; Brewster DW
Toxicol Appl Pharmacol; 1997 Jan; 142(1):133-42. PubMed ID: 9007042
[TBL] [Abstract][Full Text] [Related]
35. Specificity of co-promoting effects of caffeine on thyroid carcinogenesis in rats pretreated with N-bis(2-hydroxypropyl)nitrosamine.
Son HY; Nishikawa A; Okazaki K; Kitamura Y; Kanki K; Lee KY; Umemura T; Hirose M
Toxicol Pathol; 2004; 32(3):338-44. PubMed ID: 15204976
[TBL] [Abstract][Full Text] [Related]
36. Induction of thyroid and liver tumors by chronic exposure to 2-methylimidazole in F344/N rats and B6C3F1 mice.
Chan PC; Sills RC; Kissling GE; Nyska A; Richter W
Arch Toxicol; 2008 Jun; 82(6):399-412. PubMed ID: 17924096
[TBL] [Abstract][Full Text] [Related]
37. Promotion of thyroid tumors in rats by pregnenolone-16alpha-carbonitrile (PCN) and polychlorinated biphenyl (PCB).
Vansell NR; Muppidi JR; Habeebu SM; Klaassen CD
Toxicol Sci; 2004 Sep; 81(1):50-9. PubMed ID: 15201439
[TBL] [Abstract][Full Text] [Related]
38. A 55-week chronic toxicity study of dietary administered kojic acid (KA) in male F344 rats.
Ota Y; Imai T; Onose J; Takami S; Cho YM; Hirose M; Nishikawa A
J Toxicol Sci; 2009 Jun; 34(3):305-13. PubMed ID: 19483384
[TBL] [Abstract][Full Text] [Related]
39. Promoting effect of phenobarbital on N-bis (2-hydroxypropyl)nitrosamine thyroid tumorigenesis in rats. Effect of varying duration of exposure to phenobarbital.
Hiasa Y; Kitahori Y; Konishi N; Enoki N; Fujita T
IARC Sci Publ; 1984; (56):77-82. PubMed ID: 6536611
[TBL] [Abstract][Full Text] [Related]
40. Mechanism of clobazam-induced thyroidal oncogenesis in male rats.
Miyawaki I; Moriyasu M; Funabashi H; Yasuba M; Matsuoka N
Toxicol Lett; 2003 Dec; 145(3):291-301. PubMed ID: 14580900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
